Q3 2022 Holdings
Filed 2022-11-14 | 132 holdings | $517.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Adapthealth Corp(AHCO) | COMMON STOCK | 00653Q102 | $154.4M | 8,223,536 | 29.8% |
| Biogen Inc(BIIB) | COM | 09062X103 | $88.1M | 330,000 | 17.0% |
| Catalyst Pharmaceuticals Inc(CPRX) | COM | 14888U101 | $62.8M | 4,896,000 | 12.1% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $44.3M | 2,966,345 | 8.6% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $39.4M | 813,112 | 7.6% |
| Brookdale SR Living Inc(BKD) | COM | 112463104 | $37.1M | 8,692,561 | 7.2% |
| Centene Corp del(CNC) | COM | 15135B101 | $36.1M | 464,000 | 7.0% |
| Alphatec Hldgs Inc(ATEC) | COM NEW | 02081G201 | $22.1M | 2,532,792 | 4.3% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $12.5M | 716,538 | 2.4% |
| Alector Inc(ALEC) | COM | 014442107 | $10.0M | 1,055,192 | 1.9% |
| Annexon Inc(ANNX) | COM | 03589W102 | $3.6M | 583,913 | 0.7% |
| Acutus MED Inc(AFIB) | COM | 005111109 | $2.3M | 2,651,667 | 0.5% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $376.0K | 19,341,024 | 0.1% |
| Glaukos Corp | NOTE 2.750% 6/1 | 377322AB8 | $355.8K | $271,752,000 | 0.1% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $302.0K | 464,252 | 0.1% |
| Aerie Pharmaceuticals Inc | NOTE 1.500%10/0 | 00771VAB4 | $170.8K | $174,372,000 | 0.0% |
| Invitae Corp | NOTE 2.000% 9/0 | 46185LAB9 | $162.2K | $206,873,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $160.7K | 1,512,714 | 0.0% |
| Sarepta Therapeutics Inc | DBCV 1.500%11/1 | 803607AB6 | $148.3K | $88,657,000 | 0.0% |
| Ionis Pharmaceuticals Inc | NOTE 4/0 | 462222AD2 | $128.5K | $127,800,000 | 0.0% |
| Tabula Rasa Healthcare Inc | NOTE 1.750% 2/1 | 873379AA9 | $115.5K | $144,516,000 | 0.0% |
| Silk RD MED Inc | COM | 82710M100 | $114.1K | 2,535,369 | 0.0% |
| Caremax Inc | COM CL A | 14171W103 | $112.5K | 15,861,090 | 0.0% |
| Apellis Pharmaceuticals Inc | NOTE 3.500% 9/1 | 03753UAB2 | $99.1K | $51,885,000 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $94.9K | 1,537,539 | 0.0% |
| Nuvasive Inc | NOTE 1.000% 6/0 | 670704AL9 | $93.7K | $96,966,000 | 0.0% |
| Viatris Inc(VTRS) | COM | 92556V106 | $90.9K | 10,673,700 | 0.0% |
| Alphatec Hldgs Inc | NOTE 0.750% 8/0 | 02081GAB8 | $81.4K | $100,000,000 | 0.0% |
| Intercept Pharmaceuticals in | NOTE 3.500% 2/1 | 45845PAC2 | $81.1K | $78,500,000 | 0.0% |
| Pacira Biosciences Inc | NOTE 0.750% 8/0 | 695127AF7 | $80.8K | $81,600,000 | 0.0% |
| Accolade Inc | NOTE 0.500% 4/0 | 00437EAB8 | $79.1K | $105,000,000 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $76.1K | 4,244,098 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $73.5K | 4,855,005 | 0.0% |
| Insmed Inc | NOTE 1.750% 1/1 | 457669AA7 | $73.2K | $75,000,000 | 0.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $65.7K | 13,740,205 | 0.0% |
| Guardant Health Inc | NOTE 11/1 | 40131MAB5 | $65.0K | $89,036,000 | 0.0% |
| Pulmonx Corp(LUNG) | COM | 745848101 | $62.0K | 3,720,901 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $57.0K | 2,891,587 | 0.0% |
| Intercept Pharmaceuticals in | NOTE 3.250% 7/0 | 45845PAA6 | $56.1K | $57,791,000 | 0.0% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $54.2K | 16,941,357 | 0.0% |
| OAK STR Health Inc | NOTE 3/1 | 67181AAB3 | $52.5K | 68,000,000 | 0.0% |
| Natera Inc | NOTE 2.250% 5/0 | 632307AB0 | $51.4K | $37,638,000 | 0.0% |
| Merus N V | COM | N5749R100 | $50.5K | 2,521,553 | 0.0% |
| Nanostring Technologies Inc | NOTE 2.625% 3/0 | 63009RAD1 | $48.7K | $57,604,000 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $46.1K | 2,491,490 | 0.0% |
| Hillevax Inc | COM | 43157M102 | $45.3K | 2,653,231 | 0.0% |
| Evolus Inc(EOLS) | COM | 30052C107 | $43.4K | 5,390,103 | 0.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $42.7K | 2,032,335 | 0.0% |
| Livongo Health Inc | NOTE 0.875% 6/0 | 539183AA1 | $42.0K | $50,000,000 | 0.0% |
| Nevro Corp | NOTE 2.750% 4/0 | 64157FAC7 | $39.6K | $42,000,000 | 0.0% |